Congressional Democrats heralded a new Government Accountability Office report (PDF) as proof that the Patient Protection and Affordable Care Act's discount prescription drug program is working as planned.
Starting in January 2011, the law stipulated that drugmakers that want their products covered under Medicare Part D must participate in the drug discount program. Under this provision, the drug manufacturers must provide a 50% discount on the price that Part D plan sponsors negotiate for brand-name drugs when beneficiaries reach the so-called doughnut hole—the gap between the initial and catastrophic coverage periods where Medicare helps pay the costs.
Read the full story: http://tinyurl.com/8n432mf
Source: Modern Healthcare
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
ViiV Healthcare is developing a self-injectable HIV drug similar to Cabenuva; HHS met with insurance companies to resolve COVID-19 vaccine coverage issues; the FDA has greenlit drugmaker Novo Nordisk to add reports of ileus, or intestinal blockage, to its Ozempic label.
Read More
2 Clarke Drive
Cranbury, NJ 08512